[{"address1": "1500 Broadway", "address2": "Suite 1401", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "332 208 6102", "website": "https://www.nuvationbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a BD2 selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform which leverages a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies to deliver anti-cancer therapeutics to cancer cells, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 51, "companyOfficers": [{"maxAge": 1, "name": "Dr. David T. Hung M.D.", "age": 65, "title": "Founder, President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 1000605, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy  Markel", "age": 58, "title": "Chief People Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Junyuan  Wang Ph.D.", "age": 50, "title": "CEO & Co-Founder of AnHeart Therapeutics and Director", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1714348800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.95, "open": 2.91, "dayLow": 2.85, "dayHigh": 3.075, "regularMarketPreviousClose": 2.95, "regularMarketOpen": 2.91, "regularMarketDayLow": 2.85, "regularMarketDayHigh": 3.075, "beta": 1.373, "forwardPE": -5.98, "volume": 1517055, "regularMarketVolume": 1517055, "averageVolume": 1379503, "averageVolume10days": 1171110, "averageDailyVolume10Day": 1171110, "bidSize": 3100, "askSize": 3200, "marketCap": 737719680, "fiftyTwoWeekLow": 0.95, "fiftyTwoWeekHigh": 4.16, "fiftyDayAverage": 2.5966, "twoHundredDayAverage": 1.76807, "currency": "USD", "enterpriseValue": 47742196, "floatShares": 135843703, "sharesOutstanding": 245728992, "sharesShort": 3192248, "sharesShortPriorMonth": 2820950, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0128999995, "heldPercentInsiders": 0.24529, "heldPercentInstitutions": 0.54854, "shortRatio": 1.31, "shortPercentOfFloat": 0.0218, "impliedSharesOutstanding": 246728992, "bookValue": 2.763, "priceToBook": 1.082157, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -75802000, "trailingEps": -0.35, "forwardEps": -0.5, "enterpriseToEbitda": -0.479, "52WeekChange": 0.86875, "SandP52WeekChange": 0.23099434, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "NUVB", "underlyingSymbol": "NUVB", "shortName": "Nuvation Bio Inc.", "longName": "Nuvation Bio Inc.", "firstTradeDateEpochUtc": 1598448600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "292fc361-56ab-3994-b08a-1a4c45c2f81b", "messageBoardId": "finmb_639036735", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.99, "targetHighPrice": 10.0, "targetLowPrice": 4.5, "targetMeanPrice": 5.9, "targetMedianPrice": 5.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 611212992, "totalCashPerShare": 2.79, "ebitda": -99600000, "totalDebt": 4007000, "quickRatio": 44.004, "currentRatio": 44.113, "debtToEquity": 0.662, "returnOnAssets": -0.09646, "returnOnEquity": -0.120299995, "freeCashflow": -41592752, "operatingCashflow": -67999000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-01"}]